Cargando…
Analysis of the subsequent treatment of osteoporosis by transitioning from bisphosphonates to denosumab, using quantitative computed tomography: A prospective cohort study
PURPOSE: Denosumab reduces bone resorption and improves bone mineral density (BMD). Studies have analyzed subsequent treatment transitioning from bisphosphonates to denosumab based on dual-energy X-ray absorptiometry scanning (DXA). Quantitative computed tomography (QCT) can help assess cortical and...
Autores principales: | Tsuchiya, Koki, Ishikawa, Koji, Kudo, Yoshifumi, Tani, Soji, Nagai, Takashi, Toyone, Tomoaki, Inagaki, Katsunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170107/ https://www.ncbi.nlm.nih.gov/pubmed/34113694 http://dx.doi.org/10.1016/j.bonr.2021.101090 |
Ejemplares similares
-
Analysis of three-dimensional bone mineral density and bone strength measured by quantitative computed tomography following denosumab discontinuation in a patient with postmenopausal osteoporosis
por: Tsuchiya, Koki, et al.
Publicado: (2019) -
High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis
por: Ishikawa, Koji, et al.
Publicado: (2018) -
Risk factors predicting osteosarcopenia in postmenopausal women with osteoporosis: A retrospective study
por: Okamura, Hiroki, et al.
Publicado: (2020) -
The effect of denosumab on pedicle screw fixation: a prospective 2-year longitudinal study using finite element analysis
por: Tani, Soji, et al.
Publicado: (2021) -
High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis
por: Ishikawa, Koji, et al.
Publicado: (2016)